-
361
Metformin Treatment in Type 2 Diabetes in Pregnancy: An Active Controlled, Parallel-Group, Randomized, Open Label Study in Patients with Type 2 Diabetes in Pregnancy
Published 2015-01-01“…In this randomized, open label study, 206 patients with type 2 diabetes in pregnancy who met the eligibility criteria were selected from the antenatal clinics. …”
Get full text
Article -
362
-
363
-
364
An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors
Published 2025-03-01“…Methods: This phase 1, open-label, dose-finding study evaluated the maximum tolerated dose (MTD), safety, efficacy, and pharmacokinetics of ESK-440 in participants with advanced or metastatic solid tumors (ClinicalTrials.gov: NCT01922752). …”
Get full text
Article -
365
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial
Published 2025-02-01“…Abstract This prospective, nonrandomized, open-label phase 2 trial (Chinese Clinical Trial Registry, ChiCTR2200061906) aimed to evaluate the effectiveness of adding the PD-1 antibody tislelizumab to perioperative chemotherapy in patients with locally advanced gastroesophageal junction adenocarcinoma (GEJA). …”
Get full text
Article -
366
-
367
-
368
-
369
A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer
Published 2025-01-01“…Methods To achieve these goals, the trial employed a randomized, open-label, two-formulation crossover dosing strategy among Chinese patients with metastatic breast cancer. …”
Get full text
Article -
370
Effect of folic acid supplementation on diminished ovarian reserve: study protocol of a single-centre, open-label, randomised, placebo-controlled clinical trial
Published 2022-07-01“…It is therefore hypothesised that folic acid may improve DOR.Methods and analysis A single-centre, open-label, randomised, placebo-controlled clinical trial is designed. …”
Get full text
Article -
371
Who’s buying organic food and why? Political consumerism, demographic characteristics and motivations of consumers in North Queensland
Published 2013-01-01Subjects: Get full text
Article -
372
Verbal Encoding Strategies in Visuo-Spatial Working Memory
Published 2025-01-01Subjects: Get full text
Article -
373
Halal Food on Airplanes in Indonesia: Does it Provide Optimal Information?
Published 2024-12-01Subjects: Get full text
Article -
374
Le « jonglage » des visiteurs entre œuvres et cartels : de l’étude d’un comportement à l’application d’un principe muséographique.
Published 2023-06-01Subjects: Get full text
Article -
375
Efficacy and Safety of Murivenna Anal Infiltration Compared to Diltiazem Topical Application in Chronic Anal Fissure: Protocol for a Prospective, Randomized, Open-Label Clinical Trial
Published 2025-02-01“…MethodsThis is an open-labeled, randomized, controlled parallel group clinical trial with a sample size of 66 participants to be randomized and allocated in a 1:1 ratio to 2 groups. …”
Get full text
Article -
376
-
377
In Vivo MRI Tracking of Mesenchymal Stromal Cells Labeled with Ultrasmall Paramagnetic Iron Oxide Particles after Intramyocardial Transplantation in Patients with Chronic Ischemic Heart Disease
Published 2019-01-01“…Labeling of MSCs did not impair long-term safety of treatment. …”
Get full text
Article -
378
-
379
Being Smart about Gluten and Gluten-free Issues, Part 2: What Retailers and Consumers Need to Know about Gluten and Gluten-Free Product Labeling
Published 2014-02-01“…The purpose of this publication is to supply retailers and consumers with easy-to-understand information about labeling as related to gluten-free products. This 3-page fact sheet was written by Abigail Dicks, Amy Harder, and Amy Simonne, and published by the UF Department of Agricultural Education and Communication, September 2013. …”
Get full text
Article -
380
Daily versus three-times-weekly azithromycin in Chinese patients with non-cystic fibrosis bronchiectasis: protocol for a prospective, open-label and randomised controlled trial
Published 2022-07-01“…This protocol describes a head-to-head clinical trial designed to compare the efficacy of two dosing regimens of azithromycin in Chinese NCFB population.Methods and analysis This prospective, open-label and randomised controlled trial will be conducted in the First People’s Hospital of Jiashan, China. …”
Get full text
Article